corvus < cost < costly

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by cost

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
000023 (2018)	Miquel B. Ekkelenkamp ; C H Van Werkhoven ; Patricia C J. Bruijning-Verhagen ; Marc J M. Bonten	[A trial to study the effect of influenza vaccination in the elderly: ethical, feasible and badly needed].
000039 (2018)	Maartje S. Jacobs [Pays-Bas] ; Femke Kaasenbrood [Pays-Bas] ; Maarten J. Postma [Pays-Bas] ; Marinus Van Hulst [Pays-Bas] ; Robert G. Tieleman [Pays-Bas]	Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
000110 (2014)	J L Gonzales [Pays-Bas] ; G J Boender [Pays-Bas] ; A R W. Elbers [Pays-Bas] ; J A Stegeman [Pays-Bas] ; A A De Koeijer [Pays-Bas]	Risk based surveillance for early detection of low pathogenic avian influenza outbreaks in layer chickens.
000116 (2014)	Remko Enserink [Pays-Bas] ; Anna Lugnér [Pays-Bas] ; Anita Suijkerbuijk [Pays-Bas] ; Patricia Bruijning-Verhagen [Pays-Bas] ; Henriette A. Smit [Pays-Bas] ; Wilfrid Van Pelt [Pays-Bas]	Gastrointestinal and respiratory illness in children that do and do not attend child day care centers: a cost-of-illness study.
000181 (2012)	Anna K. Lugnér [Pays-Bas] ; Michiel Van Boven ; Robin De Vries ; Maarten J. Postma ; Jacco Wallinga	Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
000227 (2010)	Marcus Richard Keogh-Brown [Royaume-Uni] ; Richard D. Smith ; John W. Edmunds ; Philippe Beutels	The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands.
000242 (2010)	Anna K. Lugnér [Pays-Bas] ; Sido D. Mylius ; Jacco Wallinga	Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.
000245 (2010)	Alies Van Lier [Pays-Bas] ; Albert Jan Van Hoek ; Wim Opstelten ; Hein J. Boot ; Hester E. De Melker	Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands.
000264 (2009)	Anna K. Lugnér [Pays-Bas] ; Maarten J. Postma	Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
000318 (2007)	Maarten J. Postma [Pays-Bas] ; Annoesjka Novak ; Huib W K F H. Scheijbeler ; Marlene Gyldmark ; Marianne L L. Van Genugten ; Jan C. Wilschut	Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.
000337 (2006)	E. Hak [Pays-Bas] ; M J Meijboom ; E. Buskens	Modelling the health-economic impact of the next influenza pandemic in The Netherlands.
000342 (2005)	L. Bonneux [Belgique]	[The threatening influenza pandemic: a national store ofoseltamivir is a waste of money].
000398 (2003)	R E Jonkers [Pays-Bas] ; W G Boersma	[Pneumococcal vaccination in adults].
000405 (2003)	Maarten J. Postma [Pays-Bas] ; Marie-Louise A. Heijnen ; Philippe Beutels ; Johannes C. Jager	Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands.
000417 (2003)	E. Hak [Pays-Bas] ; S. Van Loon ; E. Buskens ; G A Van Essen ; D. De Bakker ; M A J B. Tacken ; B A Van Hout ; D E Grobbee ; Th J M. Verheij	Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study.
000425 (2002)	W B F. Brouwer [Pays-Bas] ; N J A. Van Exel ; M A Koopmanschap ; F F H. Rutten	Productivity costs before and after absence from work: as important as common?
000437 (2001)	M J Postma [Pays-Bas] ; M L Heijnen ; J C Jager	Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands.
000462 (1998)	E. Hak [Pays-Bas] ; G A Van Essen ; E. Buskens ; W. Stalman ; R A De Melker	Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands.
000463 (1998)	R M Baltussen [Pays-Bas] ; A. Reinders ; M J Sprenger ; M J Postma ; J C Jager ; A J Ament ; R M Leidl	Estimating influenza-related hospitalization in The Netherlands.
000468 (1997)	E M Smit	[Cost-effectiveness of influenza vaccination in The Netherlands].
000469 (1997)	A. Reinders ; M J Postma ; T M Govaert ; M J Sprenger	[Cost-effectiveness of influenza vaccination The Netherlands].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "cost" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "cost" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippePaysBasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    cost
}}

---

This area was generated with Dilib version V0.6.35. Data generation: Mon Aug 10 10:18:30 2020. Site generation: Sat Mar 27 13:53:34 2021